TY - JOUR
T1 - Mechanisms and cellular functions of intramembrane proteases
AU - Urban, Siniša
N1 - Funding Information:
I am deeply grateful to the many colleagues worldwide for making this field such an exciting and enjoyable area in which to work. I also wish to extend my sincere thanks to the authors of our Special Issue, and to the BBA editorial staff, for giving so generously of their time and effort to this project. I am also indebted to the members of my lab for many stimulating discussions over the years; our research is supported by the National Institutes of Health, the Howard Hughes Medical Institute, the David and Lucile Packard Foundation, and the Johns Hopkins University.
PY - 2013
Y1 - 2013
N2 - The turn of the millennium coincided with the branding of a fundamentally different class of enzyme - proteases that reside immersed inside the membrane. This new field was the convergence of completely separate lines of research focused on cholesterol homeostasis, Alzheimer's disease, and developmental genetics. None intended their ultimate path, but soon became a richly-integrated fabric for an entirely new field: regulated intramembrane proteolysis. Our aim in this Special Issue is to focus on the ancient and nearly ubiquitous enzymes that catalyze this unexpected yet important reaction. The pace of progress has been dramatic, resulting in a rapidly-expanding universe of known cellular functions, and a paradigm shift in the biochemical understanding of these once heretical enzymes. More recently, the first therapeutic successes have been attained by targeting an intramembrane protease. We consider these advances and identify oncoming opportunities in four parts: growing spectra of cellular roles, insights into biochemical mechanisms, therapeutic strategies, and newly-emerging topics. Recent studies also expose challenges for the future, including non-linear relationships between substrate identification and physiological functions, and the need for potent and specific, not broad-class, inhibitors.
AB - The turn of the millennium coincided with the branding of a fundamentally different class of enzyme - proteases that reside immersed inside the membrane. This new field was the convergence of completely separate lines of research focused on cholesterol homeostasis, Alzheimer's disease, and developmental genetics. None intended their ultimate path, but soon became a richly-integrated fabric for an entirely new field: regulated intramembrane proteolysis. Our aim in this Special Issue is to focus on the ancient and nearly ubiquitous enzymes that catalyze this unexpected yet important reaction. The pace of progress has been dramatic, resulting in a rapidly-expanding universe of known cellular functions, and a paradigm shift in the biochemical understanding of these once heretical enzymes. More recently, the first therapeutic successes have been attained by targeting an intramembrane protease. We consider these advances and identify oncoming opportunities in four parts: growing spectra of cellular roles, insights into biochemical mechanisms, therapeutic strategies, and newly-emerging topics. Recent studies also expose challenges for the future, including non-linear relationships between substrate identification and physiological functions, and the need for potent and specific, not broad-class, inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=84885374946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885374946&partnerID=8YFLogxK
U2 - 10.1016/j.bbamem.2013.07.001
DO - 10.1016/j.bbamem.2013.07.001
M3 - Editorial
C2 - 23831604
AN - SCOPUS:84885374946
SN - 0005-2736
VL - 1828
SP - 2797
EP - 2800
JO - Biochimica et Biophysica Acta - Biomembranes
JF - Biochimica et Biophysica Acta - Biomembranes
IS - 12
ER -